Christina Szalinski
Freelance Science Writer at Freelance
Freelance writer with a PhD in cell bio. Focused on health, science, family & food. Bylines: The Atlantic, NYTimes, SciAm, Undark & more.
Articles
-
2 weeks ago |
cancertodaymag.org | Christina Szalinski
IN AUGUST 2024, the Food and Drug Administration (FDA) granted accelerated approval for a T-cell receptor therapy to treat a rare cancer called synovial sarcoma—a soft tissue cancer that grows into the connective tissue near the joints. This cancer affects about 1,000 people—many of whom are young adults—in the U.S. each year. The median survival in people who are diagnosed with advanced synovial sarcoma is just 16.2 months, according to one study.
-
1 month ago |
francais.medscape.com | Christina Szalinski
Les rêves fascinent l’humanité depuis des millénaires, interprétés comme des présages divins dans les cultures anciennes ou comme des révélateurs de désirs inconscients selon Freud. Les neurosciences modernes les étudient comme une fenêtre sur la conscience, car ils représentent un état altéré naturel dans lequel le cerveau génère des expériences complexes et internes. Quels enjeux pour la recherche ?
-
1 month ago |
medscape.com | Christina Szalinski
Dreams have captivated humanity for millennia, interpreted as divine omens in ancient cultures or as Freudian insights into unconscious desires. Modern neuroscience explores dreams as a window into consciousness because they provide a naturally occurring altered state where the brain generates complex, internally-driven experiences.
-
1 month ago |
dairynews.today | Christina Szalinski |Stephen Trowell
In the evolving landscape of the South Caucasus, Azerbaijan's food industry is quietly undergoing a transformation — and Milla Dairy LLC is emerging as one of its most strategic players. The local dairy producer, already a leader in the domestic market, is now positioning itself at the forefront of innovation and international cooperation. One of the most notable signs of this shift comes through its growing relationship with SIG, a global provider of advanced packaging solutions.
-
1 month ago |
dairynews.today | Christina Szalinski |Stephen Trowell
In an ambitious move, Arcor and Danone declared their intent to purchase the entirety of La Serenísima, Argentina's largest dairy company generating US$ 1.4 billion in sales across 2024. Despite being a delicate proposal ordered from Paris, the offer, intended to capitalize on a prior 2020 acquisition of 49%, was met with resistance.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 977
- Tweets
- 1K
- DMs Open
- No